• Erythrocyte Lysis in Translational Bone Research

  2026-10-01

  A mechanistic and strategic guide to using selective erythrocyte removal to improve blood-derived assays in translational bone and immunology research, with practical guidance for flow cytometry, nucleic acid extraction, and protein workflows.

• Z-VAD-FMK for Apoptosis and Ferroptosis Studies

  2026-10-01

  Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor for separating caspase-dependent apoptosis from alternative cell-death programs. This guide translates its mechanism into practical workflows for THP-1, Jurkat T-cell, and cancer-cell assays, with special emphasis on ferroptosis research inspired by the NeuroD1-GPX4 study.

• Z-VAD-FMK in Apoptosis Research Workflows

  2026-09-30

  Z-VAD-FMK provides a practical, cell-permeable way to test whether a phenotype depends on caspase-driven apoptosis rather than another regulated cell-death program. This guide connects inhibitor dosing, caspase activity measurement, immune-cell workflows, and ferroptosis-focused cancer research to improve experimental interpretation.

• A40926 Workflow for Cell-Wall Antibiotic Research

  2026-09-30

  A40926 is a dalbavancin precursor that links mechanistic cell-wall studies with practical antibacterial screening, resistant-pathogen profiling, and glycopeptide pathway engineering. This workflow shows how to select assay conditions, interpret MIC results, and troubleshoot experimental variability across Gram-positive and Neisseria models.

• Z-VAD-FMK: Mechanism and Apoptosis Research

  2026-09-29

  Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor used to test whether apoptosis contributes to a cellular phenotype. Evidence from NSCLC models shows that z vad fmk can restore viability after statin–erlotinib co-treatment, while product information supports applications in apoptosis inhibition, immune-cell regulation, and pathway analysis.

• Doxycycline Hyclate for MMP–BBB Assay Design

  2026-09-29

  Doxycycline hyclate is a matrix metalloproteinases inhibitor with particular value in blood–brain barrier research. This article translates recent arsenic neurotoxicity findings into a practical assay-design framework that separates MMP target engagement, barrier protection, and cognitive or inflammatory outcomes.

• AG-490: JAK2/STAT6 Assay Workflows

  2026-09-28

  AG-490 (Tyrphostin B42) helps test whether exosome-driven macrophage polarization depends on JAK2-associated signaling in hepatocellular carcinoma models. This workflow combines practical dosing, phosphoprotein timing, flow cytometry, and orthogonal RNA readouts while accounting for AG-490’s broader EGFR and ErbB2 activity.

• Gamithromycin: From Ribosome to Respiratory Translation

  2026-09-28

  A translational framework for connecting Gamithromycin’s 50S ribosomal target to serum-aware MIC testing, lung exposure, and PK/PD study design. We examine the evidence from a murine Pasteurella multocida model, its limits for veterinary translation, and practical considerations for researchers working with Gamithromycin (ML-1709460).

• Hydroxychloroquine Sulfate: Research Workflow

  2026-09-27

  Hydroxychloroquine Sulfate (B4874) is an aqueous-compatible research reagent for probing autophagy and TLR7/9-related signaling in autoimmune disease research. It is not a suitable choice when a protocol requires DMSO or ethanol dissolution or long-term storage of prepared solutions.

• Deoxycholic Acid Sodium Salt for NSCLC Assays

  2026-09-26

  Use deoxycholic acid sodium salt as an adjustable detergent for protein extraction—not as a substitute for the RNA-targeting or immunotherapy interventions in the SNORA38B study. This guide shows how to pilot it for NSCLC pathway immunoblots, protect phosphoprotein readouts, and avoid workflows where detergent disrupts the biology you want to measure.

• H 89 2HCl: Practical PKA Assay Guidance

  2026-09-25

  A scenario-based guide to using H 89 2HCl (SKU B2190) to probe cAMP/PKA signaling while managing dose, solvent, viability-assay, and kinase-selectivity limitations. Includes practical preparation parameters and an evidence-conscious framework for selecting a research-grade source.

• Chlorin e6 (Ce6): Reliable PDT Assay Design

  2026-09-25

  Learn how to design interpretable cell assays with Chlorin e6 (Ce6), from light and oxygen controls to endpoint selection and product qualification. The guide covers practical use of SKU B8314, including its documented purity, DMSO solubility, and storage conditions.

• Red Blood Cell Lysis Buffer for Research Workflows

  2026-09-24

  Selective erythrocyte removal can make blood and tissue-derived cell preparations more workable for flow cytometry and leukocyte-focused molecular assays. This guide pairs practical starting conditions for Red Blood Cell Lysis Buffer with the limits researchers should consider when connecting blood-sample workflows to osteoblast studies.

• Novobiocin Sodium in Anti-Parasitic Assay Design

  2026-09-24

  Novobiocin Sodium is an aminocoumarin antibiotic whose activity has also been examined in an in vitro Toxoplasma gondii model. This article explains how to interpret that evidence, separate parasite effects from host-cell toxicity, and design follow-up assays without assuming that bacterial DNA gyrase is the parasite target.

• Wild vs Cultivated Taihangia rupestris Bioactivity

  2026-09-23

  A 2026 study compared wild, mountain-cultivated, and foothill-cultivated Taihangia rupestris leaves by combining UPLC-MS/MS profiling with antioxidant and α-glucosidase assays. Foothill-grown material showed the strongest measured activities, while compound screening linked phenolics and flavonoids to both radical-scavenging and enzyme-inhibitory potential.

527 records 1/36 page Next 12345 下5页 Last page